top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

iXCells and Rosebud Team Up on Human Organoid Models

Partnership integrates scalable iPSC workflows with AI-driven 3D organoids to improve drug safety prediction and translational decision-making in rare diseases.

 Featured Articles. 

7-format11240.jpg

Sanome Partners With NHS Trusts to Deploy AI-Powered Clinical Intelligence for Earlier Infection Detection

7-format11240.jpg
HEALTH

NHS Delivers First CAR-T Treatment for Adult B-cell ALL Patient

7-format11240.jpg
BIOTECH

Unexpected Protein Structure May Lead to New Cancer Treatments

7-format11240.jpg
BIOTECH

First Human Egg 'Rejuvenation' Offers Hope for Older IVF Patients

7-format11240.jpg
PHARMA

Belite Bio Announces Landmark Phase 3 Success for Stargardt Disease

7-format11240.jpg
HEALTH

Lundbeck Reports Seizure Reductions in Rare Childhood-Onset Epilepsies

7-format11240.jpg
BIOTECH

Meet the Workhorses Behind Biologics' Next Growth Wave

7-format11240.jpg
SUSTAINABILITY

Hidden Contrails in Clouds Could Be Worsening Aviation’s Climate Impact

7-format11240.jpg
HEALTH

WHO Prequalifies Shanchol®, Securing Global Supply of India’s Oral Cholera Vaccine

 Latest News. 

28th January, 2026

01.

iXCells and Rosebud Team Up on Human Organoid Models

Partnership integrates scalable iPSC workflows with AI-driven 3D organoids to improve drug safety prediction and translational decision-making in rare diseases.

16th January, 2026

02.

NHS Delivers First CAR-T Treatment for Adult B-Cell ALL Patient

Pioneering 'living drug' offers new hop for adults with agressive leukaemia.

14th January, 2026

03.

SPT Labtech and Twist Bioscience Team-up to Automate NGS Library Prep Workflows

New validated protocols on SPT's firefly platform aim to boost throughput and reproducibility for sequencing labs. 

9th January, 2026

04.

First Human Egg 'Rejuvenation' Offers Hope for Older IVF Patients

German biotech, Ovo Labs, claims breakthrough treatment could nearly halve chromosome errors in eggs, potentially transforming success rates for women over 35.

Editor's Selects.

Weighing the Cost of Semaglutide

Women's Health Therapeutics Market Enters Transformative Growth Phase

Feeding The Future of Medicine

Biotechnology in Agriculture - Feeding the World’s Growing Population

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page